Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacy
-
Published:2019-05
Issue:5
Volume:70
Page:1008-1015
-
ISSN:0168-8278
-
Container-title:Journal of Hepatology
-
language:en
-
Short-container-title:Journal of Hepatology
Author:
Yurdaydin CihanORCID, Abbas Zaigham, Buti Maria, Cornberg MarkusORCID, Esteban Rafael, Etzion Ohad, Gane Edward J., Gish Robert G.ORCID, Glenn Jeffrey S., Hamid Saeed, Heller Theo, Koh Christopher, Lampertico PietroORCID, Lurie Yoav, Manns Michael, Parana Raymundo, Rizzetto Mario, Urban StephanORCID, Wedemeyer Heiner, Wranke A., Pinheiro Borzacov L.M., Lobato C., Hamid S., Ceausu E., Dalekos G.N., Turcanu A., Niro G.A., Lubna F., Abbas M., Ingiliz P., Ferenci P., Vanwolleghem T., Hayden T., Dashdorj N., Motoc A., Hardtke S.
Reference62 articles.
1. Orphanet 2019. https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=402823. 2. Hepatitis D virus: introduction and epidemiology;Rizzetto;Cold Spring Harbor Perspect Med,2015 3. Epidemiology, pathogenesis and management of delta hepatitis: update and challenges ahead;Wedemeyer;Nat Rev Gastroenterol Hepatol,2010 4. Natural history and treatment of chronic delta hepatitis;Yurdaydin;J Viral Hepat,2010 5. Hepatitis delta virus;Hughes;Lancet,2011
Cited by
93 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|